190 related articles for article (PubMed ID: 220843)
1. Apomorphine stereotypies and transmitter mechanisms in the striatum. I. Changes in the apomorphine stereotypies caused by drugs acting on the GABA-ergic, dopaminergic and cholinergic transmission.
Georgiev VP; Markovska VL; Petkova BP
Acta Physiol Pharmacol Bulg; 1978; 4(3):56-64. PubMed ID: 220843
[TBL] [Abstract][Full Text] [Related]
2. Apomorphine stereotypies and transmitter mechanisms in the striatum. II. Interactions between GABA-ergic and cholinergic transmission.
Georgiev VP; Petkova BP
Acta Physiol Pharmacol Bulg; 1978; 4(3):65-70. PubMed ID: 220844
[TBL] [Abstract][Full Text] [Related]
3. Interrelations between dopaminergic and GABA-ergic transmitter mechanisms in apomorphine stereotypy.
Markovska V; Georgiev V
Acta Physiol Pharmacol Bulg; 1982; 8(3):67-73. PubMed ID: 6820612
[TBL] [Abstract][Full Text] [Related]
4. Role of dopaminergic and GABA-ergic interactions in seizure susceptibility.
György L
Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):280-6. PubMed ID: 526081
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
Koltai MZ; György L
Acta Physiol Acad Sci Hung; 1981; 58(3):225-33. PubMed ID: 7348023
[TBL] [Abstract][Full Text] [Related]
6. Effect of the new gamma-aminobutyric acid agonist SL 76 002 on striatal acetylcholine: relation to neuroleptic-induced extrapyramidal alterations.
Bartholini G; Scatton B; Zivkovic B
Adv Biochem Psychopharmacol; 1980; 24():207-13. PubMed ID: 6105775
[TBL] [Abstract][Full Text] [Related]
7. Study of the participation of the dopaminergic transmission system in the effects of two newly synthesized barbiturates.
Getova D; Markovska V
Acta Physiol Pharmacol Bulg; 1988; 14(2):56-62. PubMed ID: 2851915
[TBL] [Abstract][Full Text] [Related]
8. [The effect of various new GABAergics on motor and oral stereotypes with apomorphine in the rat].
Vamvakidès A; Kassianidès A; Papadopoulou-Daifoti Z
J Pharmacol; 1985; 16(4):403-11. PubMed ID: 4094437
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic, GABA-ergic and cholinergic interaction in the regulation of striatal acetylcholine concentration.
Sethy VH
Res Commun Chem Pathol Pharmacol; 1978 Aug; 21(2):359-62. PubMed ID: 358340
[TBL] [Abstract][Full Text] [Related]
10. Involvement of transmitter mechanisms in the behavioural effects of angiotensin II.
Georgiev V
Pol J Pharmacol Pharm; 1990; 42(6):553-62. PubMed ID: 1983291
[TBL] [Abstract][Full Text] [Related]
11. [Modulation of dopaminergic receptor sensitivity in the central nervous system: important parameters in synaptic function regulation].
Costentin J
Encephale; 1979; 5(2):121-49. PubMed ID: 38958
[TBL] [Abstract][Full Text] [Related]
12. Significance of the cerebral dopaminergic neurotransmission for the individual differences in learning and memory (experiments on rats).
Kehayov R; Markovska V; Kamburova T
Acta Physiol Pharmacol Bulg; 1989; 15(1):76-82. PubMed ID: 2549763
[TBL] [Abstract][Full Text] [Related]
13. On certain relationships between gamma-aminobutyric acid (GABA) and dopaminergic agents in pentylenetetrazol convulsions.
Roussinov KS; Lazarova MB
Acta Physiol Pharmacol Bulg; 1978; 4(3):43-9. PubMed ID: 220842
[No Abstract] [Full Text] [Related]
14. Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei.
Wolfarth S
Pol J Pharmacol Pharm; 1976; 28(5):469-93. PubMed ID: 796834
[No Abstract] [Full Text] [Related]
15. Effect of combined treatment with dopaminergic and GABA-ergic drugs on the threshold for maximal electroconvulsions in mice.
Czuczwar SJ
Pol J Pharmacol Pharm; 1981; 33(1):25-35. PubMed ID: 6265890
[TBL] [Abstract][Full Text] [Related]
16. Some central effects of angiotensin II. Interactions with dopaminergic transmission.
Georgiev V; György L; Getova D; Markovska V
Acta Physiol Pharmacol Bulg; 1985; 11(4):19-26. PubMed ID: 3012944
[TBL] [Abstract][Full Text] [Related]
17. Regulation of gamma-aminobutyric acid metabolism in different brain structures by cholinergic and adrenergic drugs.
Balakleevsky AI; Bobrova NP; Shevtchenko NV
Ann Ist Super Sanita; 1978; 14(1):133-8. PubMed ID: 756168
[TBL] [Abstract][Full Text] [Related]
18. Effects of cholinergic and GABAergic drugs on apomorphine-induced gnawing behavior in rats.
Rastogi SK; Rastogi RB; Singhal RL; Lapierre YD
Biol Psychiatry; 1982 Aug; 17(8):937-46. PubMed ID: 6288127
[TBL] [Abstract][Full Text] [Related]
19. Substantia nigra as a station that not only transmits, but also transforms, incoming signals for its behavioural expression: striatal dopamine and GABA-mediated responses of pars reticulata neurons.
Cools AR; Jaspers R; Kolasiewicz W; Sontag KH; Wolfarth S
Behav Brain Res; 1983 Jan; 7(1):39-49. PubMed ID: 6297521
[No Abstract] [Full Text] [Related]
20. [Interactions of GABAergic and catecholaminergic neurotransmissions. Effects of dopaminergic and noradrenergic agonists and antagonists on GABA turnover].
Bernasconi R; Steulet AF; Aryee D; Martin P; Leonhardt T; Bischoff S; Maitre L
Encephale; 1989; 15(4):377-85. PubMed ID: 2572414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
